Athanor Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,406
| Closed | -$926K | – | 818 |
|
|
2021
Q1 | $926K | Sell |
5,406
-9,396
| -63% | -$1.61M | 0.02% | 333 |
|
|
2020
Q4 | $3.25M | Buy |
14,802
+10,230
| +224% | +$2.25M | 0.07% | 116 |
|
|
2020
Q3 | $759K | Sell |
4,572
-11,878
| -72% | -$1.97M | 0.03% | 254 |
|
|
2020
Q2 | $1.88M | Buy |
+16,450
| New | +$1.88M | 0.1% | 112 |
|
|
2020
Q1 | – | Sell |
-22,500
| Closed | -$2.9M | – | 359 |
|
|
2019
Q4 | $2.9M | Buy |
22,500
+1,840
| +9% | +$237K | 0.13% | 78 |
|
|
2019
Q3 | $1.61M | Buy |
20,660
+13,760
| +199% | +$1.07M | 0.1% | 75 |
|
|
2019
Q2 | $711K | Buy |
+6,900
| New | +$711K | 0.09% | 74 |
|